ACTIVE

Farmaceutica

Export PDF

Financial year 2026 · Closed on 30/06/2026

Net result-473,3 €-118,6 %over 1 year
Revenue181,8 k €+12,1 %over 1 year
Equity183,7 k €-0,3 %over 1 year

Identity

Source · BCE/KBO

Farmaceutica is a Non-profit organization incorporated in 2000. Its main activity is: Other personal service activities n.e.c.. Its registered office is in Leuven.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0473.789.966
Incorporation
21/11/2000
Legal form
Non-profit organization
Registered office
Herestraat 49 box 423
3000 Leuven · FlandreSee on map
Latest accounts
30/06/2026
Signals
Solid equityLow riskGood liquidity

Financials

Source · NBB, 6 filings

Trend over 6 financial years

20262025202420232022
Income statement
Revenue181,8 k €162,2 k €174,5 k €145,5 k €–
EBITDA-642,6 €14,4 k €15,5 k €11,8 k €9 k €
Operating result-642,6 €14,4 k €15,5 k €11,8 k €9 k €
Net result-473,3 €2,5 k €15,9 k €11,7 k €6,7 k €
Balance sheet
Equity183,7 k €184,1 k €181,6 k €165,7 k €153,9 k €
Total assets184,1 k €186 k €185,4 k €169,1 k €156,1 k €
Cash178,1 k €169,5 k €154 k €154,4 k €146,1 k €
Debts483,4 €1,8 k €3,8 k €3,5 k €2,2 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€
See the valuation

Board of directors

Source · NBB, accounts to 30/06/2026

3 active · 15 ended

Active mandates

Sem Drummen

Chairman of the board of directors

Active
Tom Buschop

Penningmeester

Active
Vincent Jennes

Vice-chairman of the board of directors

Active

Ended mandates

Anke Van Hees

Penningmeester

Ended
Arthur Van Zeir

Vice-chairman of the board of directors

Ended
Bernd Geebelen

Chairman of the board of directors

Ended
Brently Berx

Chairman of the board of directors

Ended

Other companies at this address

Herestraat 49 3000 Leuven
CompanyCBE no.
ALFAGEN: Alumni van de FAculteit GENeeskunde KU Leuven● Active
0410.876.855
APOTHEEK DE HALLEN● Active
0823.041.535
Association internationale pour l'Etude de l'Ostéosynthèse, Section belge - Internationale Vereniging voor de Studie der Osteosyntese, Afdeling België● Active
0416.464.352
Belgian Association for Neuro-Oncology● Active
0875.672.448
BELGIAN ASSOCIATION FOR PAEDIATRIC ANAESTHESIOLOGY● Active
0500.683.811
BELGIAN ASSOCIATION FOR REGIONAL ANESTHESIA● Active
0476.083.423
Belgian College of Neuropsychopharmacology and Biological Psychiatry● Active
0415.048.548
Belgian Environmental Mutagen Society● Active
0423.884.357
Belgian Society for Occupational Hygiene● Active
0445.599.291
Belgian Society for Tissue Engineering● Active
0715.913.646
BELGIAN SOCIETY ON THROMBOSIS AND HAEMOSTASIS● Active
0450.076.733
Belgian Thyroid Club● Active
0758.644.918
BELGISCHE VERENIGING VOOR ASSISTENTEN NEUS, KEEL- EN OORZIEKTEN (VA-NKO)● Active
0700.911.508
Beroepsvereniging van de Geneesheren en Tandartsen van UZ Leuven● Active
0541.610.683
Centrum voor Ontwikkelingsstoornissen Leuven - Limburg● Active
0431.898.141
Centrum voor Rampengeneeskunde en Rampenmanagement● Active
0447.755.859
CoBioRes● Active
0525.845.116
Diana vzw● Active
0644.654.377
Eros● Active
0563.361.944
European Burns Association - Europese Brandwondenvereniging● Active
0461.516.003

Full financial information

Source · NBB
202620252024202320222021
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/07/202501/07/202401/07/202301/07/202201/07/202101/07/2020
Closing of the financial year30/06/202630/06/202530/06/202430/06/202330/06/202230/06/2021
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date17/09/202612/01/202610/01/202503/01/202427/01/202324/01/2022
General meeting12/09/202601/12/202515/10/202409/09/202317/12/202218/12/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 6 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model30/06/202612/09/202617/09/2026DutchPDF
Micro model30/06/202501/12/202512/01/2026DutchPDF
Micro model30/06/202415/10/202410/01/2025DutchPDF
Micro model30/06/202309/09/202303/01/2024DutchPDF
Micro model30/06/202217/12/202227/01/2023DutchPDF
Micro model30/06/202118/12/202124/01/2022DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 30/06/2026

3 active · 15 ended

Active mandates

Sem Drummen

Chairman of the board of directors

Active
Tom Buschop

Penningmeester

Active
Vincent Jennes

Vice-chairman of the board of directors

Active

Ended mandates

Anke Van Hees

Penningmeester

Ended
Arthur Van Zeir

Vice-chairman of the board of directors

Ended
Bernd Geebelen

Chairman of the board of directors

Ended
Brently Berx

Chairman of the board of directors

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates08/07/2026
    Beëindiging en benoeming van het Bestuursorgaan
    PDF
  • Mandates19/06/2025
    Beëindiging en benoeming van het Bestuursorgaan
    PDF
  • Mandates13/08/2024
    Beëindiging en benoeming Bestuursorgaan
    PDF
  • Mandates07/07/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates01/08/2022
    ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Mandates05/07/2021
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates02/07/2020
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates12/06/2019
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2026
    Annual accounts 2026-473,3 €↓
  2. 2025
    Annual accounts 20252,5 k €↓
  3. 2024
    Annual accounts 202415,9 k €↑
  4. 2023
    Annual accounts 202311,7 k €↑
  5. 2022
    Annual accounts 20226,7 k €↓
  6. 2021
    Annual accounts 202118,4 k €
  7. 21/11/2000
    IncorporationNon-profit organization